{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:05:12Z","timestamp":1790636712699,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000092","name":"Ontario Genomics Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"crossref","award":["115766"],"award-info":[{"award-number":["115766"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymeth.2019.11.017","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T12:14:58Z","timestamp":1575375298000},"page":"30-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Chemical probes for protein arginine methyltransferases"],"prefix":"10.1016","volume":"175","author":[{"given":"Alice Shi Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Eram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Bolotokova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo C.","family":"dela Se\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Vedadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrm3915","article-title":"Non-histone protein methylation as a regulator of cellular signalling and function","volume":"16","author":"Biggar","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.ymeth.2019.11.017_b0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.celrep.2018.08.002","article-title":"PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes","volume":"24","author":"Hamard","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ymeth.2019.11.017_b0015","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43676","article-title":"Structural insights into SETD3-mediated histidine methylation on beta-actin","volume":"8","author":"Guo","year":"2019","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbapap.2018.10.010","article-title":"Evaluation of kinetic data: What the numbers tell us about PRMTs","volume":"1867","author":"Frankel","year":"2019","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"issue":"14","key":"10.1016\/j.ymeth.2019.11.017_b0025","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/acs.chemrev.8b00008","article-title":"Chemical and biochemical perspectives of protein lysine methylation","volume":"118","author":"Luo","year":"2018","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(03)00090-2","article-title":"Many paths to methyltransfer: a chronicle of convergence","volume":"28","author":"Schubert","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pro.2838","article-title":"Effect of methylation on the side-chain pKa value of arginine","volume":"25","author":"Evich","year":"2016","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/prot.24724","article-title":"Frequent side chain methyl carbon-oxygen hydrogen bonding in proteins revealed by computational and stereochemical analysis of neutron structures","volume":"83","author":"Yesselman","year":"2015","journal-title":"Proteins"},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0045","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1074\/jbc.M111.336271","article-title":"Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues","volume":"287","author":"Zurita-Lopez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.ymeth.2019.11.017_b0050","doi-asserted-by":"crossref","first-page":"33016","DOI":"10.1074\/jbc.M113.518803","article-title":"NDUFAF7 methylates arginine 85 in the NDUFS2 subunit of human complex I","volume":"288","author":"Rhein","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.ymeth.2019.11.017_b0055","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1074\/jbc.271.25.15034","article-title":"The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase","volume":"271","author":"Lin","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0060","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1074\/jbc.275.11.7723","article-title":"PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells","volume":"275","author":"Tang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"Pt 5","key":"10.1016\/j.ymeth.2019.11.017_b0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1242\/jcs.039933","article-title":"Human protein arginine methyltransferases in vivo\u2013distinct properties of eight canonical members of the PRMT family","volume":"122","author":"Herrmann","year":"2009","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.ymeth.2019.11.017_b0070","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4161\/cc.4.12.2250","article-title":"The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity","volume":"4","author":"Boisvert","year":"2005","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1101\/gad.1279805","article-title":"Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control","volume":"19","author":"Boisvert","year":"2005","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.ymeth.2019.11.017_b0080","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4161\/cc.4.7.1830","article-title":"Methylation of MRE11 regulates its nuclear compartmentalization","volume":"4","author":"Boisvert","year":"2005","journal-title":"Cell Cycle"},{"issue":"5531","key":"10.1016\/j.ymeth.2019.11.017_b0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1060781","article-title":"Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor","volume":"293","author":"Wang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ymeth.2019.11.017_b0090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019001282","article-title":"PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD(+) Acute Myeloid Leukemia","author":"He","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0095","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-18-3211","article-title":"Methylation of C\/EBPalpha by PRMT1 inhibits its tumor-suppressive function in breast cancer","volume":"79","author":"Liu","year":"2019","journal-title":"Cancer Res."},{"issue":"32","key":"10.1016\/j.ymeth.2019.11.017_b0100","doi-asserted-by":"crossref","first-page":"28624","DOI":"10.1074\/jbc.M201053200","article-title":"Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha","volume":"277","author":"Qi","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0105","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.yexcr.2006.03.001","article-title":"The arginine methyltransferase PRMT2 binds RB and regulates E2F function","volume":"312","author":"Yoshimoto","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0110","first-page":"17","article-title":"PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X","volume":"162","author":"Vhuiyan","year":"2017","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20090268","article-title":"Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4","volume":"421","author":"Lakowski","year":"2009","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0120","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1038\/s41467-018-06968-7","article-title":"PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma","volume":"9","author":"Dong","year":"2018","journal-title":"Nat. Commun."},{"issue":"48","key":"10.1016\/j.ymeth.2019.11.017_b0125","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/onc.2013.500","article-title":"Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein","volume":"33","author":"Zhong","year":"2014","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ymeth.2019.11.017_b0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/me.2013-1403","article-title":"PRMT2 and RORgamma expression are associated with breast cancer survival outcomes","volume":"28","author":"Oh","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0135","first-page":"2604","article-title":"Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-alpha36","volume":"39","author":"Shen","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymeth.2019.11.017_b0140","doi-asserted-by":"crossref","first-page":"1547452","DOI":"10.1155\/2018\/1547452","article-title":"Protein arginine methyltransferase 2 inhibits angiotensin II-induced proliferation and inflammation in vascular smooth muscle cells","volume":"2018","author":"Zeng","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"42","key":"10.1016\/j.ymeth.2019.11.017_b0145","doi-asserted-by":"crossref","first-page":"32974","DOI":"10.1074\/jbc.M006445200","article-title":"PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain","volume":"275","author":"Frankel","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.ymeth.2019.11.017_b0150","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/sj.emboj.7600265","article-title":"PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits","volume":"23","author":"Bachand","year":"2004","journal-title":"EMBO J."},{"issue":"Pt 1","key":"10.1016\/j.ymeth.2019.11.017_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20041466","article-title":"Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3)","volume":"386","author":"Swiercz","year":"2005","journal-title":"Biochem. J."},{"issue":"26","key":"10.1016\/j.ymeth.2019.11.017_b0160","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1021\/bi6024897","article-title":"A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation","volume":"46","author":"Zou","year":"2007","journal-title":"Biochemistry"},{"issue":"29","key":"10.1016\/j.ymeth.2019.11.017_b0165","doi-asserted-by":"crossref","first-page":"20408","DOI":"10.1074\/jbc.M802329200","article-title":"Promiscuous modification of the nuclear poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior","volume":"283","author":"Fronz","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1087057111422256","article-title":"Fluorescence-based methods for screening writers and readers of histone methyl marks","volume":"17","author":"Allali-Hassani","year":"2012","journal-title":"J. Biomol. Screen."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010008","article-title":"Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression","volume":"11","author":"Hsu","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/db13-1394","article-title":"PRMT3 regulates hepatic lipogenesis through direct interaction with LXRalpha","volume":"64","author":"Kim","year":"2015","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0185","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bbadis.2019.02.012","article-title":"Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice","volume":"1865","author":"Hoekstra","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"5423","key":"10.1016\/j.ymeth.2019.11.017_b0190","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1126\/science.284.5423.2174","article-title":"Regulation of transcription by a protein methyltransferase","volume":"284","author":"Chen","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0195","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.biochem.5b01071","article-title":"CARM1 preferentially methylates H3R17 over H3R26 through a random kinetic mechanism","volume":"55","author":"Jacques","year":"2016","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.ymeth.2019.11.017_b0200","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1021\/bi002631b","article-title":"Methylation of histone H3 by coactivator-associated arginine methyltransferase 1","volume":"40","author":"Schurter","year":"2001","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/embo-reports\/kvf052","article-title":"PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays","volume":"3","author":"Lee","year":"2002","journal-title":"EMBO Rep."},{"issue":"9","key":"10.1016\/j.ymeth.2019.11.017_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500463","article-title":"MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs","volume":"1","author":"Wang","year":"2015","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1101\/gad.1141704","article-title":"A methylation-mediator complex in hormone signaling","volume":"18","author":"Xu","year":"2004","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.ymeth.2019.11.017_b0220","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.celrep.2018.08.066","article-title":"CARM1 methylates GAPDH to regulate glucose metabolism and is suppressed in liver cancer","volume":"24","author":"Zhong","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0225","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.molcel.2016.09.028","article-title":"Arginine methylation of MDH1 by CARM1 inhibits glutamine metabolism and suppresses pancreatic cancer","volume":"64","author":"Wang","year":"2016","journal-title":"Mol. Cell"},{"issue":"47","key":"10.1016\/j.ymeth.2019.11.017_b0230","doi-asserted-by":"crossref","first-page":"28408","DOI":"10.18632\/oncotarget.25400","article-title":"Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression","volume":"9","author":"Nakayama","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","article-title":"CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis","volume":"25","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0240","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1074\/jbc.M108786200","article-title":"The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity","volume":"277","author":"Frankel","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7164","key":"10.1016\/j.ymeth.2019.11.017_b0245","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature06166","article-title":"Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive","volume":"449","author":"Guccione","year":"2007","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ymeth.2019.11.017_b0250","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1101\/gad.447007","article-title":"PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation","volume":"21","author":"Hyllus","year":"2007","journal-title":"Genes Dev."},{"issue":"7164","key":"10.1016\/j.ymeth.2019.11.017_b0255","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nature06160","article-title":"Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation","volume":"449","author":"Kirmizis","year":"2007","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.ymeth.2019.11.017_b0260","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1093\/nar\/gks767","article-title":"The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes","volume":"40","author":"Stein","year":"2012","journal-title":"Nucl. Acids Res."},{"issue":"9","key":"10.1016\/j.ymeth.2019.11.017_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22590","article-title":"Significant association of PRMT6 hypomethylation with colorectal cancer","volume":"32","author":"Pan","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"10","key":"10.1016\/j.ymeth.2019.11.017_b0270","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.18632\/oncotarget.23809","article-title":"The prognostic significance of protein arginine methyltransferase 6 expression in colon cancer","volume":"9","author":"Lim","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0275","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.celrep.2018.09.053","article-title":"PRMT6 Regulates RAS\/RAF Binding and MEK\/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation","volume":"25","author":"Chan","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/carcin\/bgy147","article-title":"Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression","volume":"40","author":"Okuno","year":"2019","journal-title":"Carcinogenesis"},{"issue":"33","key":"10.1016\/j.ymeth.2019.11.017_b0285","doi-asserted-by":"crossref","first-page":"53018","DOI":"10.18632\/oncotarget.10061","article-title":"Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer","volume":"7","author":"Almeida-Rios","year":"2016","journal-title":"Oncotarget"},{"issue":"38","key":"10.1016\/j.ymeth.2019.11.017_b0290","doi-asserted-by":"crossref","first-page":"32890","DOI":"10.1074\/jbc.M506944200","article-title":"PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.ymeth.2019.11.017_b0295","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1523\/JNEUROSCI.0591-17.2017","article-title":"Loss of protein arginine methyltransferase 8 alters synapse composition and function, resulting in behavioral defects","volume":"37","author":"Penney","year":"2017","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0300","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jnc.13921","article-title":"Network-based characterization of the synaptic proteome reveals that removal of epigenetic regulator Prmt8 restricts proteins associated with synaptic maturation","volume":"140","author":"Lee","year":"2017","journal-title":"J. Neurochem."},{"issue":"35","key":"10.1016\/j.ymeth.2019.11.017_b0305","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1523\/JNEUROSCI.3389-17.2018","article-title":"Arginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons","volume":"38","author":"Simandi","year":"2018","journal-title":"J. Neurosci."},{"issue":"39","key":"10.1016\/j.ymeth.2019.11.017_b0310","doi-asserted-by":"crossref","first-page":"27872","DOI":"10.1074\/jbc.M113.491092","article-title":"Automethylation of protein arginine methyltransferase 8 (PRMT8) regulates activity by impeding S-adenosylmethionine sensitivity","volume":"288","author":"Dillon","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.ymeth.2019.11.017_b0315","doi-asserted-by":"crossref","first-page":"36444","DOI":"10.1074\/jbc.M704650200","article-title":"Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain","volume":"282","author":"Sayegh","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0320","first-page":"309","article-title":"EWS is a substrate of type I protein arginine methyltransferase, PRMT8","volume":"22","author":"Kim","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0325","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/prot.22004","article-title":"Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state","volume":"72","author":"Pahlich","year":"2008","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061576","article-title":"Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo","volume":"8","author":"Scaramuzzino","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0335","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3892\/ol.2017.5671","article-title":"PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer","volume":"13","author":"Hernandez","year":"2017","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.ymeth.2019.11.017_b0340","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/jcb.25508","article-title":"Novel protein arginine methyltransferase 8 isoform is essential for cell proliferation","volume":"117","author":"Hernandez","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"35","key":"10.1016\/j.ymeth.2019.11.017_b0345","doi-asserted-by":"crossref","first-page":"32971","DOI":"10.1074\/jbc.M105412200","article-title":"PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins","volume":"276","author":"Branscombe","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.ymeth.2019.11.017_b0350","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1073\/pnas.1209814109","article-title":"Crystal structure of the human PRMT5:MEP50 complex","volume":"109","author":"Antonysamy","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"21","key":"10.1016\/j.ymeth.2019.11.017_b0355","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1128\/MCB.24.21.9630-9645.2004","article-title":"Human SWI\/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes","volume":"24","author":"Pal","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0360","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nsmb.1568","article-title":"PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing","volume":"16","author":"Zhao","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.ymeth.2019.11.017_b0365","first-page":"4359","article-title":"PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1","volume":"45","author":"Gao","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymeth.2019.11.017_b0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s42003-018-0275-4","article-title":"MEP50\/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH\/NUMB complex","volume":"2","author":"Abe","year":"2019","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148905","article-title":"PRMT5-Mediated Methylation of NF-kappaB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-alpha and IFN-gamma Costimulation","volume":"11","author":"Harris","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0380","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2017.01.019","article-title":"PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination","volume":"65","author":"Clarke","year":"2017","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.ymeth.2019.11.017_b0385","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.celrep.2017.11.096","article-title":"PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression","volume":"21","author":"Chiang","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0390","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695917","article-title":"Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer","volume":"39","author":"Wu","year":"2017","journal-title":"Tumour Biol."},{"issue":"19","key":"10.1016\/j.ymeth.2019.11.017_b0395","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1074\/jbc.RA119.007640","article-title":"Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT\/beta-catenin and AKT\/GSK3beta proliferative signaling","volume":"294","author":"Chung","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0400","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12964-019-0344-4","article-title":"PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis","volume":"17","author":"Qin","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.ymeth.2019.11.017_b0405","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2018.04.019","article-title":"Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family\/FGFR3 signaling","volume":"427","author":"Jing","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymeth.2019.11.017_b0410","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1038\/ncomms7428","article-title":"PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.ymeth.2019.11.017_b0415","doi-asserted-by":"crossref","first-page":"16723","DOI":"10.1074\/jbc.M115.659433","article-title":"Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2","volume":"290","author":"Hadjikyriacou","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0420","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cas.13598","article-title":"PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K\/Akt\/GSK-3beta\/Snail signaling","volume":"109","author":"Jiang","year":"2018","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0425","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.18632\/oncotarget.13672","article-title":"MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1alpha protein","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"52","key":"10.1016\/j.ymeth.2019.11.017_b0430","doi-asserted-by":"crossref","first-page":"37010","DOI":"10.1074\/jbc.M113.525345","article-title":"Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions","volume":"288","author":"Feng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.ymeth.2019.11.017_b0435","doi-asserted-by":"crossref","first-page":"32604","DOI":"10.1074\/jbc.M114.609271","article-title":"Substrate specificity of human protein arginine methyltransferase 7 (PRMT7): the importance of acidic residues in the double E loop","volume":"289","author":"Feng","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0440","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1091\/mbc.E18-05-0330","article-title":"PRMT7 methylates eukaryotic translation initiation factor 2alpha and regulates its role in stress granule formation","volume":"30","author":"Haghandish","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymeth.2019.11.017_b0445","article-title":"PRMT7 methylates and suppresses GLI2 binding to SUFU thereby promoting its activation","author":"Vuong","year":"2019","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0450","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1096\/fj.201601196R","article-title":"Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression","volume":"31","author":"Geng","year":"2017","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0455","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.18632\/oncotarget.3072","article-title":"Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression","volume":"6","author":"Baldwin","year":"2015","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.ymeth.2019.11.017_b0460","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1158\/0008-5472.CAN-14-0800","article-title":"PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer","volume":"74","author":"Yao","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymeth.2019.11.017_b0465","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.2147\/OTT.S166412","article-title":"PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2","volume":"11","author":"Cheng","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ymeth.2019.11.017_b0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0475","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/cge.12884","article-title":"Loss of the arginine methyltranserase PRMT7 causes syndromic intellectual disability with microcephaly and brachydactyly","volume":"91","author":"Kernohan","year":"2017","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0480","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/s41467-018-07606-y","article-title":"Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation","volume":"9","author":"Pyun","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2019.11.017_b0485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.isci.2018.09.023","article-title":"PRMT1 deficiency in mouse juvenile heart induces dilated cardiomyopathy and reveals cryptic alternative splicing products","volume":"8","author":"Murata","year":"2018","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0490","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12020-018-1740-z","article-title":"The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes","volume":"63","author":"Porta","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0495","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/cb200519y","article-title":"Current chemical biology approaches to interrogate protein methyltransferases","volume":"7","author":"Luo","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0500","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ab.2009.09.005","article-title":"A fast and efficient method for quantitative measurement of S-adenosyl-L-methionine-dependent methyltransferase activity with protein substrates","volume":"398","author":"Suh-Lailam","year":"2010","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0505","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1087057111414903","article-title":"Scintillation proximity assay of arginine methylation","volume":"17","author":"Wu","year":"2012","journal-title":"J. Biomol. Screen."},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0510","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17460441.3.11.1267","article-title":"Scintillation proximity assay in lead discovery","volume":"3","author":"Khawaja","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"issue":"23","key":"10.1016\/j.ymeth.2019.11.017_b0515","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M401853200","article-title":"Small molecule regulators of protein arginine methyltransferases","volume":"279","author":"Cheng","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0520","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1039\/b921912a","article-title":"A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors","volume":"6","author":"Quinn","year":"2010","journal-title":"Mol. BioSyst."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1087057111416659","article-title":"Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4","volume":"17","author":"Gauthier","year":"2012","journal-title":"J. Biomol. Screen."},{"issue":"10","key":"10.1016\/j.ymeth.2019.11.017_b0530","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/1087057111422943","article-title":"TR-FRET cellular assays for interrogating posttranslational modifications of histone H3","volume":"16","author":"Machleidt","year":"2011","journal-title":"J. Biomol. Screen."},{"issue":"7","key":"10.1016\/j.ymeth.2019.11.017_b0535","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/cbic.201300029","article-title":"A TR-FRET-based functional assay for screening activators of CARM1","volume":"14","author":"Zeng","year":"2013","journal-title":"ChemBioChem"},{"issue":"8","key":"10.1016\/j.ymeth.2019.11.017_b0540","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nmeth.3472","article-title":"Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation","volume":"12","author":"Marcon","year":"2015","journal-title":"Nat. Meth."},{"issue":"7","key":"10.1016\/j.ymeth.2019.11.017_b0545","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/cb2000567","article-title":"Expanding cofactor repertoire of protein lysine methyltransferase for substrate labeling","volume":"6","author":"Islam","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"20","key":"10.1016\/j.ymeth.2019.11.017_b0550","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1021\/ja2006719","article-title":"Labeling substrates of protein arginine methyltransferase with engineered enzymes and matched S-adenosyl-L-methionine analogues","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ymeth.2019.11.017_b0555","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1074\/jbc.M109.063784","article-title":"In vivo residue-specific histone methylation dynamics","volume":"285","author":"Zee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0560","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ab.2006.01.004","article-title":"An enzyme-coupled continuous spectrophotometric assay for S-adenosylmethionine-dependent methyltransferases","volume":"350","author":"Dorgan","year":"2006","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0565","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ab.2010.03.010","article-title":"An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases","volume":"401","author":"Ibanez","year":"2010","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.ymeth.2019.11.017_b0570","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1021\/ac200816m","article-title":"Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay","volume":"83","author":"Hemeon","year":"2011","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0575","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ab.2005.04.007","article-title":"A coupled fluorescent assay for histone methyltransferases","volume":"342","author":"Collazo","year":"2005","journal-title":"Anal. Biochem."},{"issue":"11","key":"10.1016\/j.ymeth.2019.11.017_b0580","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1039\/c1mb05230f","article-title":"Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors","volume":"7","author":"Wang","year":"2011","journal-title":"Mol. BioSyst."},{"issue":"8","key":"10.1016\/j.ymeth.2019.11.017_b0585","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.str.2012.06.001","article-title":"An allosteric inhibitor of protein arginine methyltransferase 3","volume":"20","author":"Siarheyeva","year":"2012","journal-title":"Structure"},{"issue":"17","key":"10.1016\/j.ymeth.2019.11.017_b0590","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1002\/anie.201412154","article-title":"A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)","volume":"54","author":"Kaniskan","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"50","key":"10.1016\/j.ymeth.2019.11.017_b0595","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1021\/bi501279g","article-title":"Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion","volume":"53","author":"Wang","year":"2014","journal-title":"Biochemistry"},{"issue":"38","key":"10.1016\/j.ymeth.2019.11.017_b0600","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1073\/pnas.1706978114","article-title":"Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0605","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/prot.20579","article-title":"Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide","volume":"61","author":"Pahlich","year":"2005","journal-title":"Proteins"},{"issue":"46","key":"10.1016\/j.ymeth.2019.11.017_b0610","doi-asserted-by":"crossref","first-page":"13370","DOI":"10.1021\/bi701558t","article-title":"Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis","volume":"46","author":"Osborne","year":"2007","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.ymeth.2019.11.017_b0615","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.1074\/jbc.M710176200","article-title":"A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism","volume":"283","author":"Lakowski","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ymeth.2019.11.017_b0620","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1074\/jbc.M111.333609","article-title":"Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6)","volume":"287","author":"Obianyo","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0625","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/febs.13953","article-title":"Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors","volume":"284","author":"Cura","year":"2017","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0630","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/jm061213n","article-title":"Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations","volume":"50","author":"Ragno","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0635","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acschembio.5b00839","article-title":"A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases","volume":"11","author":"Eram","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0640","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acsmedchemlett.5b00071","article-title":"Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound","volume":"6","author":"Mitchell","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0645","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/BJ20102161","article-title":"Structural basis for CARM1 inhibition by indole and pyrazole inhibitors","volume":"436","author":"Sack","year":"2011","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ymeth.2019.11.017_b0650","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/acs.jmedchem.5b01772","article-title":"Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor","volume":"59","author":"Ferreira de Freitas","year":"2016","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ymeth.2019.11.017_b0655","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.6b01033","article-title":"Discovery of a potent, selective, and cell-active dual inhibitor of protein arginine methyltransferase 4 and protein arginine methyltransferase 6","volume":"59","author":"Shen","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0660","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/ml500467h","article-title":"Discovery of a dual PRMT5-PRMT7 inhibitor","volume":"6","author":"Smil","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0665","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","article-title":"Anti-tumor activity of the Type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss","volume":"36","author":"Fedoriw","year":"2019","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ymeth.2019.11.017_b0670","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.ymeth.2019.11.017_b0675","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1093\/nar\/gkz200","article-title":"PRMT1 loss sensitizes cells to PRMT5 inhibition","volume":"47","author":"Gao","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ymeth.2019.11.017_b0680","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/cb2001473","article-title":"Activity-based protein profiling of protein arginine methyltransferase 1","volume":"6","author":"Obianyo","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymeth.2019.11.017_b0685","unstructured":"Structural Genomics Consortium, SGC6870 A chemical probe for PRMT6, 2019. https:\/\/thesgc.org\/chemical-probes\/SGC6870. (Accessed 24 June 2019)."},{"issue":"14","key":"10.1016\/j.ymeth.2019.11.017_b0690","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1021\/acs.jmedchem.6b00668","article-title":"Discovery of a potent and selective coactivator associated arginine methyltransferase 1 (CARM1) inhibitor by virtual screening","volume":"59","author":"Ferreira de Freitas","year":"2016","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.ymeth.2019.11.017_b0695","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.18632\/oncotarget.24883","article-title":"TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma","volume":"9","author":"Nakayama","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymeth.2019.11.017_b0700","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47110","article-title":"A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion","volume":"8","author":"Cai","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0705","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 inhibitor with potent in vitro and in vivo activity in preclinical models of multiple myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ymeth.2019.11.017_b0710","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ymeth.2019.11.017_b0715","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1038\/s41598-018-28002-y","article-title":"Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing","volume":"8","author":"Gerhart","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2019.11.017_b0720","unstructured":"Structural Genomics Consortium, GSK591 A chemical probe for PRMT5, 2015. https:\/\/thesgc.org\/chemical-probes\/GSK591. (Accessed 15 June 2019)."},{"issue":"13 Supplement","key":"10.1016\/j.ymeth.2019.11.017_b0725","article-title":"Abstract 4859: JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer models","volume":"78","author":"Wu","year":"2018","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.ymeth.2019.11.017_b0730","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1021\/acs.jmedchem.7b00587","article-title":"Potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor developed by structure-based virtual screening and hit optimization","volume":"60","author":"Mao","year":"2017","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ymeth.2019.11.017_b0735","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/cbdd.12881","article-title":"Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations","volume":"89","author":"Ji","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.ymeth.2019.11.017_b0740","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/acsmedchemlett.8b00014","article-title":"LLY-283, a potent and selective inhibitor of arginine methyltransferase 5, PRMT5, with antitumor activity","volume":"9","author":"Bonday","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ymeth.2019.11.017_b0745","doi-asserted-by":"crossref","unstructured":"M.M. Szewczyk, Y. Ishikawa, S. Organ, N. Sakai, F. Li, L. Halabelian, S. Ackloo, M. Eram, D. Dilworth, H. Fukushi, R. Harding, C.C. dela Se\u00f1a, T. Sugo, K. Hayashi, D. Macleod, C. Zepeda, S. Takagi, R. Al-Awar, S. Richard, M. Takizawa, C.H. Arrowsmith, M. Vedadi, P.J. Brown, H. Nara, D. Barsyte-Lovejoy, Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response, bioRxiv (2019) 503136.","DOI":"10.1101\/503136"},{"key":"10.1016\/j.ymeth.2019.11.017_b0750","unstructured":"Structural Genomics Consortium, SGC3027 for PRMT7, 2018. https:\/\/thesgc.org\/chemical-probes\/SGC3027. (Accessed 15 June 2019)."},{"issue":"9","key":"10.1016\/j.ymeth.2019.11.017_b0755","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"issue":"43","key":"10.1016\/j.ymeth.2019.11.017_b0760","doi-asserted-by":"crossref","first-page":"15835","DOI":"10.1073\/pnas.0605224103","article-title":"Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination","volume":"103","author":"Vedadi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319302464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319302464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:37:39Z","timestamp":1760924259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202319302464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":152,"alternative-id":["S1046202319302464"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2019.11.017","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical probes for protein arginine methyltransferases","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2019.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}